Role of CD151 expression in gallbladder carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• CD151 is a tetraspanin protein implicated in tumor progression, including metastasis and angiogenesis.
• Its interaction with integrins and other tetraspanins highlights its role in cancer pathobiology.
• Understanding CD151's role in gallbladder cancer (GBC) is crucial for clinical applications.

Purpose of the Study:

• To investigate the clinical significance of CD151 expression in gallbladder cancer.
• To determine if CD151 expression can serve as a prognostic indicator for GBC patients.
• To explore the association between CD151 expression and clinicopathological factors.

Main Methods:

• Retrospective analysis of 45 surgically treated GBC patients.
• Immunohistochemical evaluation of CD151 expression in tumor specimens.
• Comparison of clinicopathological factors, including Ki-67 and matrix metallopeptidase 9 (MMP-9), between CD151-positive and CD151-negative groups.

Main Results:

• CD151 expression was observed in 58% of GBC cases.
• CD151-positive patients had significantly poorer 5-year survival (29%) compared to CD151-negative patients (78%, P = .006).
• CD151 expression correlated with lymphatic invasion, curability, and MMP-9 expression, and was an independent prognostic factor (HR 2.97, P = .02).

Conclusions:

• CD151-positive expression is a significant independent prognostic factor in gallbladder cancer.
• CD151 may serve as a valuable prognostic biomarker for GBC.
• Targeting CD151 could be a potential therapeutic strategy for regulating tumor metastasis in GBC.